Journal: Nutrients
Article Title: New Trends to Treat Muscular Atrophy: A Systematic Review of Epicatechin
doi: 10.3390/nu16020326
Figure Lengend Snippet: Summary of the main EC supplementation parameters–Studies in culture cells.
Article Snippet: Edwards et al., 2022 [ ] , Epi: #E1753 Sigma , Mouse skeletal muscle C2C12 myoblasts , To investigate the effects of EC and HA (hippuric acid) on skeletal muscle morphology and metabolism investigating an in vitro model of muscle atrophy with dexamethasone. , Divided into 6 groups: VC-CTRL: vehicle control. VC-DEX: cells incubated in dexamethasone; EPI-CTL: cells incubated with 25 μM EC; EPI + DEX: cells were incubated in 25 μM EC and 100 μM DEX; HA-CTL: cells incubated in 25 μM HA.; HA + DEX: cells incubated with 25 μM HA and 100 μM DEX , 25 μM EPI and 100 μM DEX. , 24h of treatment protocol , Cells were incubated in DMEM (5mM glucose), followed by 6 days of differentiation, and received 24 h of treatment. , PGC1 α, ACC, and TFAM (regulators of mitochondrial function) were significantly lower in DEX-treated versus CTL cells (Control). However, EPI or HA partially attenuated the proteolysis in DEX-treated groups by preserving the expression of LC3 and caspase-3 protein. Myotube diameter was significantly greater in EPI-DEX and HA- DEX. p ≤ 0.05.
Techniques: Negative Control, Incubation, Positive Control, Cell Culture, Differentiation Assay, Cell Differentiation, Expressing, In Vitro, Preserving